Seven MammaTyper® Studies Published in SGBCC
Studies add further evidence of clinical utilities of MammaTyper® in breast cancer subtyping and precision medicine BERLIN, CHINA, March 14, 2025 /EINPresswire.com/ -- Cerca Biotech GmbH announces that in the 19th St. Gallen Breast Cancer …